$4.4M investment headed to A2 pharmamceutical company
Ann Arbor-based Meditrina Pharmaceuticals Inc. was awarded $4.4 million in start-up funds that will allow the company to proceed with a Phase 2 clinical trial for a drug that might be used to treat several women's health issues.


